Cost-Effectiveness of Icosapent Ethyl (IPE) for the Reduction of the Risk of Ischemic Cardiovascular Events in Canada by Lachaine J, Charron JN, Gregoire JC, Hegele RA, Leiter LA

Get full text

Dalcetrapib reduces risk of new-onset diabetes in patients with coronary heart disease by Schwartz, GG, Leiter, LA, Ballantyne, CM, Preiss, D, Et al.